SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

Child's Limp Revealed a Surprising 'Disease of the Past'

Even healthy, normal-weight children suffer malnourishment and its consequences

Record High GLP-1 Use; Intense Interval Exercise; Endometriosis and Androgens

— News and commentary from the endocrinology world

BMI Extremes Tied to Worse Pregnancy Outcomes With ART

BMI appears to have a greater impact on pregnancy continuation than on achieving initial implantation or pregnancy. Study findings suggest promoting proactive BMI optimization before treatment.

India's New Transgender Rules Worry Doctors, Disrupt Care

Mehr Khan, an Indian transgender woman, arrived for a routine hormone therapy appointment only to discover the crucial treatment had been suspended after a recent change in the law.

Kailera Shares Tumble on High Nausea Rates Despite Weight-loss Drug's Success

Kailera Therapeutics' shares dropped 10% on Tuesday after its oral weight-loss drug showed high rates ⁠of nausea and vomiting among participants in a late-stage trial in...

Pharmacist-Led Outreach Improves SGLT2 Inhibitor Uptake

Patients with chronic kidney disease and type 2 diabetes receiving pharmacist-led outreach were nearly twice as likely to start an SGLT2 inhibitor as those receiving usual care.

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Todays Updates

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

A retrospective study evaluates outcomes associated with first-line enfortumab vedotin plus pembrolizumab vs gemcitabine plus cisplatin in patients with metastatic urothelial carcinoma.

Germline Variants Predict Lobular Breast Cancer Recurrence

For women with invasive lobular carcinoma, pathogenic variants in breast cancer risk genes predict high odds of early recurrence.

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Higher background parenchymal enhancement on breast MRI may signal greater risk among women who carry BRCA mutations.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

Patients with relapsed or refractory diffuse large B-cell lymphoma, who were ineligible for autologous stem cell transplant, were randomly assigned to receive Pola-R-GemOx or R-GemOx.

Latest News

Even healthy, normal-weight children suffer malnourishment and its consequences

— News and commentary from the endocrinology world

BMI appears to have a greater impact on pregnancy continuation than on achieving initial implantation or pregnancy. Study findings suggest promoting proactive BMI optimization before treatment.

Mehr Khan, an Indian transgender woman, arrived for a routine hormone therapy appointment only to discover the crucial treatment had been suspended after a recent change in the law.

Kailera Therapeutics' shares dropped 10% on Tuesday after its oral weight-loss drug showed high rates ⁠of nausea and vomiting among participants in a late-stage trial in...

Patients with chronic kidney disease and type 2 diabetes receiving pharmacist-led outreach were nearly twice as likely to start an SGLT2 inhibitor as those receiving usual care.

News All Time

Drug Fights GLP-1 Muscle Loss; Unapproved Retatrutide Prescriptions; Protein Swap

News and commentary from the endocrinology world

Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes

Investigational pill was well-tolerated and doesn't come with food or water restrictions

First Guideline on Cardiovascular-Kidney-Metabolic Syndrome Released

Guideline targets cardiologists, endocrinologists, nephrologists, and primary care clinicians

The Diabetes Burden Inside and Outside the ADA Conference Hall

Research, funding, policy, and an environmental understanding must all come together

Video: ADA Leader Apologizes to Researchers Ejected From Meeting

CEO says the organization will commission a review of the events

FDA Issues Safety Alert on Weight-Loss Drug's Kidney Risks

All orlistat products will now carry a warning about kidney stones or kidney injury

Endocrine Society Issues First Guideline on Central Precocious Puberty

"Children are entering puberty younger than in past decades," guideline panel co-chair says

Not Enough Men on Testosterone Get Guideline-Based Hypogonadism Work-Up

Data highlight "quite a discrepancy in testosterone prescribing practice," researcher says

Medicare's GLP-1 Program Looms; Chemicals in Breast Milk; Acromegaly Drug Rejected

News and commentary from the endocrinology world

Menopause Experts Release Guidance on Non-Hormone Therapy for Hot Flashes

Comorbidity-specific recommendations will help those with contraindications to hormone therapy

Real-World Study Backs Menopausal Hormone Therapy for Stronger Bones

Clinical guidance still calls for a nuanced approach in postmenopausal women

FTC Sues Leading Transgender Health Group

The suit alleges the group made deceptive claims about gender-affirming care for minors

Lifestyle Treatments as Important as Medications in Managing Obesity in Kids, Teens

Semaglutide combined with counseling "emerged as the most potent intervention"

White House Denies Trump Got Unapproved Obesity Drug

Compassionate use of retatrutide granted for someone with sleep apnea, pulmonary hypertension

Few IVF Add-Ons Have Any Proven Benefits, Study Shows

An evidence-based website could help patients better understand these treatments

Are People With Eating Disorders Misusing GLP-1 Drugs?

This group may be taking the weight-loss drugs in contraindicated ways, researchers suggest

Recommended News For You

Hematocrit Stabilized in Polycythemia Vera Under Novel Hepcidin Mimetic Treatment.

Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.

Chemotherapy can be a challenging treatment?here's how to deal with some of the side-effects

More People Than Previously Believed Have Schizophrenia.

Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

A consensus statement from researchers on the proper use of Lu-177 PSMA-617 radionuclide therapy and patient selection is published.

Recommended Articles For You

Exploring the Latest Treatments for Essential Thrombocythemia 

Comprehensive Developments in Hematology in Daily Practice 

The Statistical Imperative: Navigating Trends, Precision, and Innovation in Gynecologic Oncology 2025 

Advanced Approaches in Oncology and Patient Outcomes 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

PSA Testing Is Not Enough for Another Candidate for Prostate Cancer Screening.

2.

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.

3.

Alkem introduces cetuximab under the trade name Cetuxa in India.

4.

Five new papers highlight cancer inequities, challenges and opportunities in South Asia

5.

Personalized Breast Cancer Treatment; Insights Into HPV in Men; Exercise and Cancer

1.

HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians

2.

Angina Haemorrhagica Bullosa: What You Need to Know

3.

Exploring the Causes and Treatments of Cysts: A Comprehensive Guide

4.

Overcoming Immunotherapy Resistance: Novel Checkpoints, Biomarkers, and Emerging Therapeutic Strategies

5.

The Unseen Danger of Anal Cancer: How to Protect Yourself

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

2.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

3.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

5.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot